Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAI-7535 in Adult Participants Living With Obesity or Overweight
NCT07497880Phase 2Active, not recruiting
- Sponsor
- Kailera Therapeutics
- Start
- Apr 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of HRS-7535 in obesity, Overweight, sponsored by Kailera Therapeutics. Started Apr 2026; status: active, not recruiting.
02
Drugs
HRS-7535
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07497880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07497880.